2023
Association between sociodemographic factors and diagnosis of lethal prostate cancer in early life
Smani S, Novosel M, Sutherland R, Jeong F, Jalfon M, Marks V, Rajwa P, Nolazco J, Washington S, Renzulli J, Sprenkle P, Kim I, Leapman M. Association between sociodemographic factors and diagnosis of lethal prostate cancer in early life. Urologic Oncology Seminars And Original Investigations 2023, 42: 28.e9-28.e20. PMID: 38161105, DOI: 10.1016/j.urolonc.2023.10.005.Peer-Reviewed Original ResearchLethal prostate cancerSociodemographic factorsAdvanced CaPAdvanced diseaseYounger patientsProstate cancerHigher oddsAdvanced stageProstate-specific antigen (PSA) screeningCharacteristics of patientsNational Cancer DatabaseRetrospective cohort studySubset of patientsPatient sociodemographic factorsMultivariable logistic regressionPatients' health insuranceHighest income quartileCohort studyAdvanced cancerAntigen screeningMean ageInsurance statusCancer DatabaseCaP screeningSociodemographic disparities
2021
MP62-17 ENZALUTAMIDE IN PATIENTS WITH LOCALIZED PROSTATE CANCER UNDERGOING ACTIVE SURVEILLANCE: ENACT
Shore N, Renzulli J, Fleshner N, Hollowell C, Vourganti S, Silberstein J, Siddiqui R, Hairston J, Elsouda D, Russell D, Cooperberg M, Tomlins S. MP62-17 ENZALUTAMIDE IN PATIENTS WITH LOCALIZED PROSTATE CANCER UNDERGOING ACTIVE SURVEILLANCE: ENACT. Journal Of Urology 2021, 206: e1099-e1099. DOI: 10.1097/ju.0000000000002102.17.Peer-Reviewed Original Research
2020
A comparison of sipuleucel-T (sip-T) product parameters from two phase III studies: PROVENT in active surveillance prostate cancer and IMPACT in metastatic castrate-resistant prostate cancer (mCRPC).
Ross A, Armstrong A, Pieczonka C, Bailen J, Tutrone R, Cooperberg M, Pavlovich C, Renzulli J, Haynes H, Sheikh N, Shore N. A comparison of sipuleucel-T (sip-T) product parameters from two phase III studies: PROVENT in active surveillance prostate cancer and IMPACT in metastatic castrate-resistant prostate cancer (mCRPC). Journal Of Clinical Oncology 2020, 38: 321-321. DOI: 10.1200/jco.2020.38.6_suppl.321.Peer-Reviewed Original ResearchMetastatic castrate-resistant prostate cancerCD54 upregulationProstate cancerOverall survivalActive surveillanceCell countCastrate-resistant prostate cancerPeripheral blood mononuclear cellsEarly-stage prostate cancerAutologous cellular immunotherapyLarger immune responsesPhase III studyBlood mononuclear cellsStage prostate cancerTotal nucleated cell countNucleated cell countIII studyCellular immunotherapyMononuclear cellsTreatment weekProstate adenocarcinomaT cellsImmune responseTNC countProvent
2018
PD52-03 THE ASSOCIATION OF EDUCATION LEVEL WITH THE UTILIZATION OF SHARED DECISION MAKING IN PROSTATE CANCER SCREENING
Pereira J, Gershman B, Renzulli J. PD52-03 THE ASSOCIATION OF EDUCATION LEVEL WITH THE UTILIZATION OF SHARED DECISION MAKING IN PROSTATE CANCER SCREENING. Journal Of Urology 2018, 199: e981-e982. DOI: 10.1016/j.juro.2018.02.2355.Peer-Reviewed Original Research
2017
MP92-19 NOVEL, NONTOXIC SKIN CARE FORMULATION ASSOCIATED WITH LOWER CAUTI RATES FOR HIGH-RISK ICU, NEURO, C-V AND TRAUMA PATIENTS WHEN USED FOR FOLEY CATHETER INSERTION AND MAINTENANCE
Turini G, Renzulli J. MP92-19 NOVEL, NONTOXIC SKIN CARE FORMULATION ASSOCIATED WITH LOWER CAUTI RATES FOR HIGH-RISK ICU, NEURO, C-V AND TRAUMA PATIENTS WHEN USED FOR FOLEY CATHETER INSERTION AND MAINTENANCE. Journal Of Urology 2017, 197: e1235. DOI: 10.1016/j.juro.2017.02.2880.Peer-Reviewed Original ResearchMP97-13 ASSOCIATION OF EXTENDED PELVIC LYMPH NODE DISSECTION WITH THROMBOEMBOLIC EVENTS AND LYMPHOCELE FORMATION AMONG MEN UNDERGOING ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY WITH PELVIC LYMPH NODE DISSECTION
Pereira J, Shillan H, Tucci C, Pareek G, Golijanin D, Gershman B, Renzulli J. MP97-13 ASSOCIATION OF EXTENDED PELVIC LYMPH NODE DISSECTION WITH THROMBOEMBOLIC EVENTS AND LYMPHOCELE FORMATION AMONG MEN UNDERGOING ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY WITH PELVIC LYMPH NODE DISSECTION. Journal Of Urology 2017, 197: e1308. DOI: 10.1016/j.juro.2017.02.3057.Peer-Reviewed Original ResearchMP14-05 THE ASSOCIATION OF AGE WITH PERIOPERATIVE MORBIDITY AND MORTALITY AMONG PATIENTS UNDERGOING RADICAL PROSTATECTOMY
Pereira J, Pareek G, Golijanin D, Renzulli J, Gershman B. MP14-05 THE ASSOCIATION OF AGE WITH PERIOPERATIVE MORBIDITY AND MORTALITY AMONG PATIENTS UNDERGOING RADICAL PROSTATECTOMY. Journal Of Urology 2017, 197: e163-e164. DOI: 10.1016/j.juro.2017.02.469.Peer-Reviewed Original Research781 Perioperative morbidity of open versus minimally invasive partial nephrectomy: A contemporary analysis of the National Surgical Quality Improvement Program (NSQIP)
Pereira J, Renzulli J, Pareek G, Moreira D, Golijanin D, Gershman B. 781 Perioperative morbidity of open versus minimally invasive partial nephrectomy: A contemporary analysis of the National Surgical Quality Improvement Program (NSQIP). European Urology Open Science 2017, 16: e1352-e1353. DOI: 10.1016/s1569-9056(17)30834-5.Peer-Reviewed Original Research
2016
The Role of a Standardized Clinical Care Pathway in Patient Satisfaction and Quality of Life Outcomes after Robotic Assisted Laparoscopic Radical Prostatectomy
Turini G, Clark M, Machan J, Tucci C, Renzulli J. The Role of a Standardized Clinical Care Pathway in Patient Satisfaction and Quality of Life Outcomes after Robotic Assisted Laparoscopic Radical Prostatectomy. Urology Practice 2016, 4: 232-238. PMID: 37592643, DOI: 10.1016/j.urpr.2016.06.006.Peer-Reviewed Original ResearchLaparoscopic radical prostatectomyStandardized care pathwayClinical care pathwayLength of stayRadical prostatectomyCare pathwayPatient satisfactionPostoperative lengthChart reviewEmergency departmentUrology officeStandardized clinical care pathwayRetrospective chart reviewOverall patient satisfactionPostoperative patient careCohort of menQuality of careLAPAROSCOPIC RADICALPathway cohortPostoperative callsReadmission ratesEarly dischargeHospital readmissionPostoperative qualitySame surgeryPresence and percentage of type 2 papillary RCC in mixed (type 1 and type 2) papillary renal cell carcinoma does not portend worse prognosis in patients treated by partial/radical nephrectomy in non-metastatic disease.
Leone A, Diorio G, Brito J, Zargar K, Pareek G, Renzulli J, Dickinson S, Amin A, Sexton W, Spiess P, Poch M, Golijanin D. Presence and percentage of type 2 papillary RCC in mixed (type 1 and type 2) papillary renal cell carcinoma does not portend worse prognosis in patients treated by partial/radical nephrectomy in non-metastatic disease. Journal Of Clinical Oncology 2016, 34: e16126-e16126. DOI: 10.1200/jco.2016.34.15_suppl.e16126.Peer-Reviewed Original ResearchMP08-05 REDUCED LENGTH OF STAY AND READMISSION RATES USING A STANDARDIZED CLINICAL CARE PATHWAY FOLLOWING ROBOTIC PROSTATECTOMY
Turini G, Clark M, Tucci C, Machan J, Golijanin D, Pareek G, Renzulli J. MP08-05 REDUCED LENGTH OF STAY AND READMISSION RATES USING A STANDARDIZED CLINICAL CARE PATHWAY FOLLOWING ROBOTIC PROSTATECTOMY. Journal Of Urology 2016, 195: e86. DOI: 10.1016/j.juro.2016.02.2250.Peer-Reviewed Original ResearchPD09-07 THE ROLE OF PATIENT RACE AND ETHNICITY IN PREDICTING PHYSICIAN RECOMMENDATION OF PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING
Turini G, Gjelsvik A, Golijanin D, Pareek G, Renzulli J. PD09-07 THE ROLE OF PATIENT RACE AND ETHNICITY IN PREDICTING PHYSICIAN RECOMMENDATION OF PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING. Journal Of Urology 2016, 195: e236. DOI: 10.1016/j.juro.2016.02.2902.Peer-Reviewed Original ResearchPD03-05 UPSTAGING IN RADICAL PROSTATECTOMY IN THE POST-PSA ERA: AN EFFECT OF DELAYED DIAGNOSIS OR BETTER PATIENT SELECTION?
Rotker K, Brito J, Edmund L, Matoso A, Renzulli J. PD03-05 UPSTAGING IN RADICAL PROSTATECTOMY IN THE POST-PSA ERA: AN EFFECT OF DELAYED DIAGNOSIS OR BETTER PATIENT SELECTION? Journal Of Urology 2016, 195: e57-e58. DOI: 10.1016/j.juro.2016.02.2093.Peer-Reviewed Original ResearchMP36-18 HIGH-RISK HPV SUBTYPES IN SQUAMOUS CELL CARCINOMA OF THE SCROTUM
Brito J, Rotker K, Lepe M, Quddus M, Manna P, Epstein J, Matoso A, Renzulli J. MP36-18 HIGH-RISK HPV SUBTYPES IN SQUAMOUS CELL CARCINOMA OF THE SCROTUM. Journal Of Urology 2016, 195: e496. DOI: 10.1016/j.juro.2016.02.1652.Peer-Reviewed Original ResearchCommunication on the Impact of Multidisciplinary Care in a Large Volume Robot-Assisted Radical Prostatectomy Program: A Paradoxical Stage Migration toward More Aggressive Disease
Leone A, Diorio G, Mega A, Renzulli J. Communication on the Impact of Multidisciplinary Care in a Large Volume Robot-Assisted Radical Prostatectomy Program: A Paradoxical Stage Migration toward More Aggressive Disease. Journal Of Medical & Surgical Pathology 2016, 1: 1-2. DOI: 10.4172/2472-4971.1000123.Peer-Reviewed Original Research
2015
Reversal of castrate resistant prostate cancer by extracellular vesicle therapy.
Mega A, Renzulli J, Quesenberry P, Chatterjee D. Reversal of castrate resistant prostate cancer by extracellular vesicle therapy. Journal Of Clinical Oncology 2015, 33: e16111-e16111. DOI: 10.1200/jco.2015.33.15_suppl.e16111.Peer-Reviewed Original ResearchMP25-10 ETIOLOGY OF SYMPTOMATIC URETHRITIS IN MEN ACCORDING TO SEXUAL BEHAVIORS
Vigneswaran H, Hwang K, Renzulli J, Chan P. MP25-10 ETIOLOGY OF SYMPTOMATIC URETHRITIS IN MEN ACCORDING TO SEXUAL BEHAVIORS. Journal Of Urology 2015, 193: e288-e289. DOI: 10.1016/j.juro.2015.02.1213.Peer-Reviewed Original ResearchMP14-17 IMMEDIATE REPEAT BIOPSY IS NOT NECESSARY IN PATIENTS WITH ATYPICAL SMALL ACINAR PROLIFERATION (ASAP): A MULTI-INSTITUTIONAL REVIEW
Leone A, Gershman B, Rotker K, Butler C, Fantasia J, Afiadata A, Li J, Sebo T, Zhou A, Jiang Z, Amin A, Mega A, Schiff S, Pareek G, Golijanin D, Yates J, Karnes R, Renzulli J. MP14-17 IMMEDIATE REPEAT BIOPSY IS NOT NECESSARY IN PATIENTS WITH ATYPICAL SMALL ACINAR PROLIFERATION (ASAP): A MULTI-INSTITUTIONAL REVIEW. Journal Of Urology 2015, 193: e157. DOI: 10.1016/j.juro.2015.02.879.Peer-Reviewed Original ResearchMP57-16 ANTIPLATELET/ANTICOAGULATION THERAPY DOES NOT INCREASE IMMEDIATE COMPLICATIONS IN PATIENTS UNDERGOING ROBOTIC PARTIAL NEPHRECTOMY (RPN)
Leone A, Turini G, Brito J, Tran T, Renzulli J, Pareek G, Golijanin D. MP57-16 ANTIPLATELET/ANTICOAGULATION THERAPY DOES NOT INCREASE IMMEDIATE COMPLICATIONS IN PATIENTS UNDERGOING ROBOTIC PARTIAL NEPHRECTOMY (RPN). Journal Of Urology 2015, 193: e695-e696. DOI: 10.1016/j.juro.2015.02.2004.Peer-Reviewed Original Research
2014
Extracellular vesicle-mediated reversal of taxane resistance and the malignant phenotype in prostate cancer.
Nadeem O, Mega A, Keller E, Renzulli J, Quesenberry P, Chatterjee D. Extracellular vesicle-mediated reversal of taxane resistance and the malignant phenotype in prostate cancer. Journal Of Clinical Oncology 2014, 32: e16028-e16028. DOI: 10.1200/jco.2014.32.15_suppl.e16028.Peer-Reviewed Original Research